cambridge's bluebird bio licenses delivery tech to novartis, gsk http://lm360.us/Beagle-son-of-Delcid-from-Boekel?Mccrossin=203
on critical illness, 4.6 per cent of claims were declined due to the definition not being met and 2.3 per cent were due to misrepresentation. .